‘Invisible’ blood detected in the stools is linked to a heightened risk of death from all causes, as well as
Continue reading »
BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia
AIRPORT CITY, Israel, July 11, 2018 /PRNewswire/ — BioSight Ltd., a pharmaceutical development company focused on the development of targeted
Continue reading »
Hypnosis may help reduce fear of cancer treatment in children: Hypnosis could help to reduce the fear of medical procedures in children and young people with cancer.
Hypnosis could help to reduce the fear of medical procedures in children and young people with cancer. New research led
Continue reading »
Structure of protein pair provides blueprint for future drugs
Walter and Eliza Hall Institute researchers have visualised for the first time how the protein SOCS1 ‘switches off’ cell signalling
Continue reading »
After 40 years in limbo: Styrene is probably carcinogenic
“Possibly carcinogenic and should be investigated more closely.” For forty years, this has been the conclusion of researchers who have
Continue reading »
Researchers find leukemia and lymphoma drug may benefit glioblastoma patients
New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also
Continue reading »
New ‘unified theory’ of childhood leukemia raises possibility of preventing the disease
Kids who develop acute lymphoblastic leukemia may be the victims of a triple-whammy stroke of bad luck, according to a
Continue reading »
New potential target identified to fight acute myeloid leukemia
AML is not a single disease. It is a group of leukemias that develop in the bone marrow from progenitors
Continue reading »
Enzyme’s movement may be key to new cancer drugs: Interfering with the motion of a kinase enzyme might be a new approach for the development of anti-cancer drugs
Revealing all the steps required to activate an enzyme called a protein kinase may identify new ways to target cancer,
Continue reading »
Depleted metabolic enzymes promote tumor growth in kidney cancer: Study identifies new renal cancer targets based on tumor metabolism
Kidney cancer, one of the ten most prevalent malignancies in the world, has increased in incidence over the last decade,
Continue reading »